[Muscular carnitine-palmityl-transferase deficiency]

Area of Science:

• Biochemistry
• Human Physiology
• Metabolic Disorders

Background:

• Recurrent paroxysmal myoglobinuria is a condition characterized by repeated episodes of muscle breakdown and the release of myoglobin into the bloodstream.
• Idiopathic myoglobinuria is diagnosed when no underlying cause for the recurrent episodes can be identified.
• Carnitine-palmityl-transferase (CPT) is a key enzyme in fatty acid metabolism, crucial for energy production in muscles.

Observation:

• A 20-year-old male patient presented with recurrent episodes of paroxysmal myoglobinuria.
• Extensive investigations failed to reveal any other identifiable cause for the patient's condition.
• Carnitine-palmityl-transferase (CPT) deficiency was subsequently identified as the underlying cause.

Findings:

• The study demonstrated carnitine-palmityl-transferase (CPT) deficiency in a patient with recurrent paroxysmal myoglobinuria.
• This deficiency was identified after other potential causes were excluded, highlighting its diagnostic significance.
• The findings directly link CPT deficiency to the observed myoglobinuria episodes.

Implications:

• Muscular carnitine-palmityl-transferase (CPT) deficiency should be considered in the differential diagnosis of recurrent paroxysmal myoglobinuria.
• Accurate diagnosis of CPT deficiency can prevent misclassification of myoglobinuria as idiopathic.
• Identifying CPT deficiency allows for targeted management and potentially prevents future episodes of myoglobinuria.